We've got a new niche!
The SCN Blog has a new name and a new home: http://www.signalsblog.ca
After nearly four years and 207 blog posts, we finally outgrew our dish, so to speak. Late last year, we began planning with the newly-formed Centre for Commercialization of Regenerative Medicine, who indicated an interest to begin blogging in the sphere. (Perhaps you'll recall our name contest?) Why have two blogs competing when one can do the job? The result is Signals Blog (the new name came from an SCN staff member who sadly was not eligible for a prize), which will continue to bring the same level of insight, commentary and research news you've found on the SCN Blog, but will add new perspectives and news on biomaterials, regenerative medicine and commercialization.
We think it's a great partnership that will provide a more comprehensive view of the world of stem cells and regenerative medicine.
To ease the transition for readers, all archived posts from the SCN Blog have been moved to their new home and RSS feeds will be updated to the new address. Comments will be closed on this site, but we'll keep a copy of the archives here for the short term.
This is our final post on this site: please update your links and check out our new niche at www.signalsblog.ca!
